Select for export Alterations of consciousness and mystical-type experiences after acute LSD in humans. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-016-4453-0 PubMed 27714429 Copy citation Copy BibTeX Psychopharmacology 2016-10-06 Liechti ME, Dolder PC, Schmid Y. Europe PMC Published psilocybin Brain ImagingConsciousnessAging Observational Study More
Select for export Psilocybin-induced psychosis in humans and in rats − translational quantitative EEG study No abstract availability was recorded for this entry. Details DOI 10.1016/s0924-977x(16)31133-6 Copy citation Copy BibTeX European Neuropsychopharmacology 2016-09-30 Filip Tylš, Čestmír Vejmola, Michaela Viktorinová, L. Kadeřábek, Tomáš Páleníček OpenAlex Published psilocybin Brain ImagingReceptor Pharmacology Other More
Select for export Psilocybin-induced decrease in amygdala-putamen coupling during an event-related face discrimination task No abstract availability was recorded for this entry. Details DOI 10.1016/s0924-977x(16)31070-7 Copy citation Copy BibTeX European Neuropsychopharmacology 2016-09-30 O. Grimm, Rainer Krähenmann, Katrin H. Preller, Erich Seifritz, F.X. Vollenweider OpenAlex Published psilocybin Receptor Pharmacology Other More
Select for export Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881116662634 PubMed 27578767 Copy citation Copy BibTeX Journal of Psychopharmacology 2016-08-29 Carbonaro TM, Bradstreet MP, Barrett FS, MacLean KA, Jesse R, Johnson MW Europe PMC Published psilocybin WellbeingEmotional ProcessingObservational Study Observational Study More
Select for export Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1093/ijnp/pyw016 PubMed 26874330 Copy citation Copy BibTeX The International Journal of Neuropsychopharmacology 2016-07-04 Maqueda AE, Valle M, Addy PH, Antonijoan RM, Puntes M, Coimbra J Europe PMC Published psilocybin AddictionMechanism of ActionReceptor Pharmacology Clinical Trial More
Select for export Sex differences and serotonergic mechanisms in the behavioural effects of psilocin. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1097/fbp.0000000000000198 PubMed 26461483 Copy citation Copy BibTeX Behavioural Pharmacology 2016-05-31 Tylš F, Páleníček T, Kadeřábek L, Lipski M, Kubešová A, Horáček J. Europe PMC Published psilocybinpsilocin PharmacologyMechanism of ActionReceptor Pharmacology Clinical Trial More
Select for export PM502. Effect of psilocybin on EEG brain connectivity in healthy volunteers - preliminary report No abstract availability was recorded for this entry. Details DOI 10.1093/ijnp/pyw041.502 Copy citation Copy BibTeX The International Journal of Neuropsychopharmacology 2016-05-26 Tomáš Páleníček, Filip Tylš, Michaela Viktorinová, Dominika Prokopcova, Jakub Korčák, Renata Androvičová OpenAlex Published psilocybin Brain ImagingHealthy Volunteers Other More
Select for export PM506. Psilocybin Clinical Trial: Acute Effects and its relationship to the brain activity as measured by quantitative EEG Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1093/ijnp/pyw041.506 Copy citation Copy BibTeX The International Journal of Neuropsychopharmacology 2016-05-26 Filip Tylš, Michaela Viktorinová, Dominika Prokopcova, Jakub Korčák, Renata Androvičová, Martin Brunovský OpenAlex Published psilocybin Brain ImagingPharmacologyReceptor Pharmacology Clinical Trial More
Select for export Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.euroneuro.2016.01.005 PubMed 26875114 Copy citation Copy BibTeX European Neuropsychopharmacology 2016-01-21 Pokorny T, Preller KH, Kraehenmann R, Vollenweider FX. Europe PMC Published psilocybin Receptor PharmacologyConsciousnessHealthy Volunteers Other More
Select for export P.1.i.005 The 5-HT2A/1A agonist psilocybin reduces social pain and enhances empathy in healthy volunteers No abstract availability was recorded for this entry. Details DOI 10.1016/s0924-977x(15)30364-3 Copy citation Copy BibTeX European Neuropsychopharmacology 2015-08-31 Katrin H. Preller, Thomas Pokorny, Rainer Krähenmann, Milan Scheidegger, I. Dziobek, Philipp Stämpfli OpenAlex Published psilocybin DepressionAnxietyChronic Pain Other More
Select for export Psilocybin-induced spiritual experiences and insightfulness are associated with synchronization of neuronal oscillations. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-015-4026-7 PubMed 26231498 Copy citation Copy BibTeX Psychopharmacology 2015-07-31 Kometer M, Pokorny T, Seifritz E, Volleinweider FX. Europe PMC Published psilocybin Brain ImagingMechanism of ActionReceptor Pharmacology Clinical Trial More
Select for export Neurovascular and neuroimaging effects of the hallucinogenic serotonin receptor agonist psilocin in the rat brain. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.neuropharm.2015.07.018 PubMed 26192543 Copy citation Copy BibTeX Neuropharmacology 2015-07-16 Spain A, Howarth C, Khrapitchev AA, Sharp T, Sibson NR, Martin C. Europe PMC Published psilocybinpsilocin Brain ImagingReceptor PharmacologyAging Animal Study More
Select for export Psychedelics not linked to mental health problems or suicidal behavior: a population study. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881114568039 PubMed 25744618 Copy citation Copy BibTeX Journal of Psychopharmacology 2015-03-04 Johansen PØ, Krebs TS. Europe PMC Published psilocybin DepressionAnxietyAddiction Other More
Select for export Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881114565144 PubMed 25586396 Copy citation Copy BibTeX Journal of Psychopharmacology 2015-01-12 Bogenschutz MP, Forcehimes AA, Pommy JA, Wilcox CE, Barbosa PC, Strassman RJ. Europe PMC Published psilocybin AddictionMechanism of ActionReceptor Pharmacology Qualitative Study More
Select for export P.1.g.005 Serotonergic modulation of emotion processing by the mixed 5-HT1A/2A receptor agonist psilocybin reduces amygdala activation to negative stimuli - a pharmacological fMRI study No abstract availability was recorded for this entry. Details DOI 10.1016/s0924-977x(14)70316-5 Copy citation Copy BibTeX European Neuropsychopharmacology 2014-09-24 Rainer Kraehenmann, Katrin H. Preller, Erich Seifritz, F.X. Vollenweider OpenAlex Published psilocybin Brain ImagingReceptor PharmacologyEmotional Processing Other More
Select for export Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881114548296 PubMed 25213996 Copy citation Copy BibTeX Journal of Psychopharmacology 2014-09-10 Johnson MW, Garcia-Romeu A, Cosimano MP, Griffiths RR. Europe PMC Published psilocybin AddictionReceptor PharmacologyBiomarkers Other More
Select for export Dimethyltryptamine (DMT): prevalence, user characteristics and abuse liability in a large global sample. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881113513852 PubMed 24284475 Copy citation Copy BibTeX Journal of Psychopharmacology 2013-11-26 Winstock AR, Kaar S, Borschmann R. Europe PMC Published psilocybin Observational StudyAbuse Liability Observational Study More
Select for export Psychiatry's next top model: cause for a re-think on drug models of psychosis and other psychiatric disorders. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881113494107 PubMed 23784738 Copy citation Copy BibTeX Journal of Psychopharmacology 2013-06-18 Carhart-Harris RL, Brugger S, Nutt DJ, Stone JM. Europe PMC Published psilocybin Depression Other More
Select for export The Use of Synthetic Cathinones and Tryptamines in a Psychiatric Population Abstract available at the source but not redistributed here. Read at source. Details DOI 10.4172/2325-9841.1000109 Copy citation Copy BibTeX Journal of Forensic Toxicology and Pharmacology 2012-12-31 lhsan M Salloum OpenAlex Published psilocybin PharmacologyToxicity Other More
Select for export The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-012-2811-0 PubMed 22836372 Copy citation Copy BibTeX Psychopharmacology 2012-07-26 Schmidt A, Kometer M, Bachmann R, Seifritz E, Vollenweider F. Europe PMC Published psilocybin Receptor PharmacologyEmotional Processing Other More
